The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ahn Chang Ho since 2008.
The trader's CIK number is 1316420.
At the time of the last reporting, Ahn Chang Ho was the Chairman & CEO of Rexahn Pharmaceuticals, Inc.. (stock ticker symbol RNN).
Also see all insider trading activities at Rexahn Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | RNN | 0 | $0 | 250,000 | $175,500 | 250,000 | $77,500 |
| 2015 | RNN | 0 | $0 | 314,656 | $286,847 | 314,656 | $251,724 |
| 2014 | RNN | 0 | $0 | 136,193 | $134,422 | 136,193 | $108,954 |
| 2011 | RNN | 1,328,924 | $1,712,014 | 0 | $0 | 0 | $0 |
| 2009 | RNN | 260,000 | $176,800 | 2,600,000 | $1,768,000 | 0 | $0 |
| 2008 | RNN | 10,000 | $23,670 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-04-10 | RNN | Option Ex | 250,000 | .31 | 77,500 |
| 2017-04-10 | RNN | Sale | 250,000 | .70 | 175,500 |
| 2015-01-08 | RNN | Option Ex | 80,000 | .80 | 64,000 |
| 2015-01-09 | RNN | Option Ex | 186,212 | .80 | 148,969 |
| 2015-01-08 | RNN | Sale | 80,000 | .90 | 72,000 |
| 2015-01-09 | RNN | Sale | 186,212 | .92 | 170,570 |
| 2015-01-12 | RNN | Option Ex | 48,444 | .80 | 38,755 |
| 2015-01-12 | RNN | Sale | 48,444 | .91 | 44,277 |
| 2014-06-12 | RNN | Sale | 136,193 | .99 | 134,422 |
| 2014-06-12 | RNN | Option Ex | 136,193 | .80 | 108,954 |
| 2011-05-18 | RNN | Buy | 1,008,078 | 1.31 | 1,320,582 |
| 2011-04-01 | RNN | Buy | 320,846 | 1.22 | 391,432 |
| 2009-05-04 | RNN | Buy | 260,000 | .68 | 176,800 |
| 2009-05-04 | RNN | Sale | 2,600,000 | .68 | 1,768,000 |
| 2008-04-14 | RXHN.OB | Buy | 10,000 | 2.37 | 23,670 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ahn Chang Ho (Chairman & CEO of Rexahn Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.